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Stepped care vs. matched care for mood and
anxiety disorders: a randomized trial in
routine practice
van Straten A, Tiemens B, Hakkaart L, Nolen WA, Donker MCH.
Stepped care vs. matched care for mood and anxiety disorders: a
randomized trial in routine practice.
Objective: The effectiveness of two versions of stepped care [with either
brief therapy (BT) or cognitive behavioural therapy (CBT) as a first
step] is studied in comparison with the traditional matched care
approach (CAU) for patients with mood and anxiety disorders.
Method: A randomized trial was performed in routine mental health
care in 12 settings, including 702 patients. Patients were interviewed
once in 3 months for 18–24 months (response rate 69%).
Results: Overall, patients health improved significantly over time:
51% had achieved recovery from the DSM-IV disorder(s) after 1 year
and 66% at the end of the study. Respectively, 50% and 60% had
normal SCL90 and SF36 scores. Cognitive behavioural therapy and
BT patients achieved recovery more often than CAU patients (ORs
between 1.26 and 1.48), although these results were not statistically
significant.
Conclusion: Stepped care, with BT or CBT as a first step, is at least as
effective as matched care.
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Significant outcomes
• Patients health improved significantly although at least one-third still suffered from a DSM-IV
disorder at the end of the study.
• Stepped care, with either brief therapy (BT) or cognitive behavioural therapy (CBT) as a first step, is
at least as effective as matched care.
• Stepped care with BT as a first step is more efficient for the mental health centre than matched care.
Limitations
• About a quarter of all patients did not start with (the assigned) treatment.
• We have no information on the actual therapeutic approaches/techniques used in the three treatment
arms.
Introduction
In the Netherlands, the 1-year prevalence for DSM-
IV mood and anxiety disorders is estimated to
be 7.6% and 12.4%, respectively (1), and the
co-morbidity between these two is known to be
high (2, 3). Mental health care for these disorders is
usually provided in out-patient Mental Health
Centres (MHCs). Care as usual (CAU) consists of
a matched care approach in which a multidiscipli-
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nary team matches client and therapy, based on
intake information about the specific problems and
patient characteristics. As a result, the treatment
may vary (e.g. interpersonal, supportive, psycho-
analytical, eclectic, with or without medication), the
intensity may vary, as well as the setting (individual,
with family or in a group). In this traditional mental
health-care approach several problems are encoun-
tered. Firstly, the longwaiting lists forCAU indicate
a significant gap between the demand for psycho-
logical therapy and the available supply. Secondly,
we have reason to believe that the percentages of
patients receiving evidence-based interventions is
low, being comparable with the percentages as
described in the international literature (4, 5).
Introducing a stepped care model may increase
effectiveness as well as efficiency of mental health
care. In a stepped-care model, all patients start with
an evidence-based treatment of low intensity as a
first step. Progress is monitored and those patients,
who do not respond adequately, will step up to a
subsequent treatment of higher intensity. Although,
thismodel seems promising, the effectiveness of such
a stepped-care model has not been proven yet, as
direct comparisons with CAU, i.e. in the Nether-
lands a matched care approach, is lacking (6).
Aims of the study
The aim of this study is to provide such a
comparison. A traditional matched care approach
(CAU) is compared with i) a stepped-care model
with brief therapy (BT) as a first step and ii) a
stepped care model with cognitive behavioural
therapy (CBT) as a first step.
Material and methods
With this trial, we aimed at resembling routine care
as closely as possible. We specifically chose not to
study stepped care in a research settingwith top level
therapists within a homogeneous sample of patients.
Instead, we chose to study the effectiveness of
stepped care as it will appear after implementation
in routine care. Therefore, the studywas performed
in MHCs, which normally provide mental health
care,with therapistswith average qualifications, and
with patients who normally present themselves at
the MHC’s (with mild to severe mood and anxiety
disorders and with or without psychiatric and/or
somatic co-morbidity).
Inclusion of patients
Dutch out-patient mental health care is provided
by 47 regional mental health care centres (MHCs).
A representative sample of seven MHCs partici-
pated in this study at 12 different settings. Both
large and small centres in urban and rural regions
were included.
Patients were enrolled in two steps (Figure).
Firstly, all patients between 18 and 65 years old
who were in need of mental health care, were
screened during the inclusion period (February
2000–October 2001) on exclusion criteria: psy-
chotic or manic symptoms, cognitive impairments
such as dementia or mental retardation, illegal
hard drug dependence (patients with alcohol
dependence were not excluded), high suicide risk,
or poor command of the Dutch language. The
remaining patients were then screened for the
presence of mood and/or anxiety disorders with
the INSTEL screen, which is a Dutch modified
version of the Goldberg-screen (7, 8). Second, all
remaining patients were interviewed at home
(baseline assessment) by a trained research assist-
ant to determine the presence of mood- and/or
anxiety disorders with the composite international
diagnostic interview (CIDI). The CIDI, a struc-
tured interview developed by the World Health
Organization (9, 10), enables trained lay interview-
ers to assess psychiatric diagnoses according to the
DSM-IV. Patients with the following DSM-IV
diagnosis were included: major depressive disorder
(single episode or recurrent), dysthymic disorder,
panic disorder (with or without agoraphobia),
social phobia, or generalized anxiety disorder,
including co-morbid diagnoses. All eligible patients
were asked to participate in the study. After full
explanation of the study, 702 patients gave written
informed consent (Fig. 1). The first patient started
treatment in March 2000. Data collection ended in
July 2003, although 26 patients were still in
treatment at that time.
Assignment and masking
As the study took place in routine settings, we had
to take into account the existing treatment capacity
in the 12 chosen settings, which led to the following
scheme: at six settings CAU vs. CBT was studied,
at three settings CAU vs. BT was studied, at two
settings BT vs. CBT was studied and at one setting
all three treatments were studied simultaneously.
We made sure that each treatment was carried out
in six different MHC’s. We used block
randomization (n ¼ 4, or 6 when randomized to
three conditions), stratified by MHC setting. The
randomization scheme was derived by computer
and managed centrally. When a patient was
included, the researchers opened an envelope and
the randomization outcome was reported to the
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MHC. Patients and therapists were informed about
the randomization outcomes, but the research
assistants who performed the interviews were
kept blind during the whole study. Power analysis
with an expected difference in outcome between
Matched Care and either one of the Stepped Care
approaches of 15%, and the usual a ¼ 0.05 and
(1)b) ¼ 0.80, prompted us to aim for inclusion of
750 patients. As the result of slower inclusion rates
than expected, we finally included a total of 702
patients: 266 CAU patients, 232 CBT patients and
204 BT patients.
Interventions
The MHCs decided which therapists participated.
The requirements were that each therapist would
participate in one condition only and that the
therapist had to be experienced in the therapy
provided. During a 1-day meeting preceding the
study with all participating BT therapists, consen-
sus was achieved on a number of core elements of
this treatment. These elements were described in a
limited protocol in which all therapists were
trained for 2 days. The same procedure was
followed in the CBT condition. CAU was not
protocolized but all therapists were informed about
the study in meetings with the researchers.
Brief therapy was introduced in the Netherlands
in the 80s as a remedy against the long waiting
lists. It rapidly gained popularity and it is currently
offered to approximately 20% of all Dutch patients
although its effectiveness has never yet been
studied (11). It is suitable as a first step in a
stepped care model as it is characterized by a quick
onset (no waiting lists) and a limited number of
sessions (five sessions and two booster sessions
within 6 months). In this study, BT was charac-
terized as follows. During the first session a scheme
was used to assess the main complaints, the
circumstances (social, work, finances etc.), and
personal functioning. Based on this scheme, a
treatment rationale was defined and a workplan
formulated. Between sessions the patients were
supposed to perform homework. In BT com-
plaints were defined as problems and patients were
learnt how to cope with these problems on their
own. Keywords were: creating hope by clarifying
the problem and emphasising and strengthening
the patients own competentions and coping abilit-
ies.
Cognitive behavioural therapy was chosen as a
standard treatment. It might also be a suitable first
step in a stepped-care model as it is a relatively
short treatment (10–15 sessions) and its effective-
ness for many types of depressive and several types
All patients between 18 – 
65 years (n = 5219) 
Step 1: intake 
• Exclusion (n = 1321) 
• Negative screen mood/anxiety disorders (n = 271) 
• Refusal home interview (n = 1593) 
• Not participating for remaining / unknown reasons (n = 426) 
• Eligible for step 2 (n = 1608)
Step 2: home interview 
• Refusal to participate in study (n = 396) 
• No DSM-IV mood or anxiety disorder present (n = 214) 
• Poor command Dutch language (n = 17) 
• Could not be reached for home interview before treatment onset (n = 279) 
• Randomised (n = 702)




Brief therapy  
n = 204
12 months after 
randomisation 
Follow-up data n = 173 
No follow-up data n = 93 
• Lost to follow-up n = 40 
• Wave non-respons n = 53
12 months after 
randomisation 
Follow-up data n = 139 
No follow-up data n = 93 
• Lost to follow-up n = 27 
• Wave non-respons n = 66
12 months after 
randomisation 
Follow-up data n = 139 
No follow-up data n = 65 
• Lost to follow-up n = 30 
• Wave non-respons n = 35
18–24 months after  
randomisation 
Follow-up data n = 183 
No follow-up data n = 83
18–24 months after 
randomisation 
Follow-up data n = 155 
No follow-up data n = 77
18–24 months after  
randomisation 
Follow-up data n = 141 
No follow-up data n = 63
Fig. 1. Patients included in the study.
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of anxiety disorders has been proven (12–15). In
this study, CBT consisted of five modules: i)
introduction (one session); ii) providing inform-
ation about the aim and the procedure of the
treatment and assessing patients cognitions (three
sessions); iii) changing cognitions by challenging
them (three sessions); iv) changing behaviour by
performing behaviour experiments while challen-
ging cognitions (three sessions); v) integrating new
behaviour in patients lives by additional behaviour
experiments (one to five sessions). All patients were
given written information about their disorder, the
most frequently occurring automatic thoughts, and
ways to challenge these automatic thoughts.
Both BT and CBT were considered as first steps
in a stepped-care model. Therefore, all patients
were allowed to switch treatments, during or after
treatment completion, should either the patient or
the therapist be convinced that the clinical effects
were insufficient. In other words: patients were
allowed to step up. Furthermore, severely ill
patients in all three treatment conditions were
allowed to receive antidepressant medication in
addition to the psychological treatment. The pre-
scription was protocolized in accordance with
current Dutch guidelines.
Outcome assessments
Patients were interviewed at baseline and then
every 3 months irrespective of waiting times for
treatment or treatment duration. Baseline assess-
ment, 1-year follow-up and the last follow-up were
face to face interviews. All other follow-ups were
brief interviews (30 min) by telephone. The final
follow-up interview was at least 18 months after
enrolment in the study. The first patients to enter
the study (n ¼ 64) could be followed for
24 months, others were followed for 21 months
(n ¼ 121) or 18 months (n ¼ 299). In analysis, we
controlled for differences in follow-up period.
Various demographics were assessed during the
baseline interview (age, gender, educational level,
ethnicity, work status (paid job or not) as well as
the presence of chronic somatic conditions (16),
and the Big Five personality dimensions (NEO-
FFI; 17): neuroticism, extraversion, openness to
experience, agreeableness and conscientiousness.
The primary outcome was recovery after
12 months and at completion of the study. Recov-
ery was defined as having no current mood or
anxiety disorder. Other outcomes were severity of
symptoms and mental health functioning, both of
which were measured during all interviews (face-to-
face and telephone). Severity of symptoms was
measured with the total score of the 90 items
Symptom CheckList (SCL90; 18). The total score
is obtained by adding the item scores, and ranges
from 90 (no distress) to 450 (extremely distressed),
where 115 (males) and 123 (females) represent the
mean scores for the population (18). Mental health
functioning refers to the mental component sum-
mary score of the Short Form SF36 (19). This
score ranges from 0 (poor mental health function-
ing) to 100 (optimal mental health functioning)
were 50 represents the mean score for the popul-
ation (20).
Attrition
At 12 months, a total of 97 patients were lost to
follow-up while another 154 patients were unable
to participate in that particular assessment. As a
result, the response rate was 64% (n ¼ 451). The
response rate at the end of the study was 68%
(n ¼ 479). The reasons for study drop-out varied:
many patients could not be reached because they
had changed telephone numbers or addresses,
others did not want to be reminded of the time
that they were depressed or anxious, or experi-
enced the interviews as a burden because of other
reasons. Furthermore, a substantial number of
patients did not give any reason for drop-out.
There were no statistically significant differ-
ences in response rates between the three treat-
ment conditions. Furthermore, we compared the
responders with the non-responders on all base-
line characteristics. The non-responders were
significantly younger than the responders (35.0
vs. 37.1 years, P < 0.01, 12 months analyses;
34.5 vs. 37.2 years, P < 0.01, 18–24 months
analyses), and scored significantly lower on the
personality trait agreeableness (mean score 4.1 vs.
4.4, P ¼ 0,05, 12 months analyses; mean score
4.1 vs. 4.4, P ¼ 0.07, 18–24 months analyses).
There were no differences with regard to the
DSM-IV mood and anxiety disorders, the SCL90
and the SF36 mental health component score
with one exception. The end of study non-
responders suffered significantly more often
from a mild (single episode) depressive disorder
than the responders (15% vs. 10%, P ¼ 0.05).
Data analyses
The association between the types of treatment and
full recovery was analysed with logistic regression
analyses. We controlled for the differences in
follow up period (18, 21 or 24 months). The
association between the types of treatment and
changes in the SCL90 and the SF36 was ana-
lysed with generalized estimating equation (GEE)
A RCT of stepped care vs. matched care
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time-lag models (21). An exchangeable correlation
structure was employed. The reported regression
coefficients are to be interpreted as the mean
differences (in the SCL90 or the SF36 scores)
between the treatment conditions over time (i.e. for
each assessment we controlled for the score on the
previous assessment). Patients with missing base-
line values (n ¼ 60 for the SCL90 and n ¼ 66 for
the SF36) could not be analysed with GEE. All
other patients were included, despite missing one
or more follow-up interviews. There were no
significant interaction effects between time and
treatment, and therefore all analyses were per-
formed without this interaction term.
All logistic and GEE analyses were performed
on both the intention to treat and the completers
sample. In the intention to treat sample, all
patients were analysed as they were randomized
while in the completers sample only patients who
had started with the assigned treatment and
finished it (with or without further referral) were
included. Of all 702 patients, 414 (59%) were
completers (60% of the CAU patients; 56% of the
CBT patients; 60% of the BT patients). Finally, all
analyses were repeated with missing data being
imputed in two ways: i) by carrying the last
observation forward and ii) by predicting the
missing values by regression analyses on the
available data based on all baseline characteristics.
Results
Demographics and health status at baseline
Most patients met the criteria for more than one
DSM-IV disorder (Table 1). Of the 702 patients in
the study, 41% suffered simultaneously from
anxiety and mood disorders, 47% suffered only
Table 1. Demographics and health status at base-










Male (%) 39 35 41 41
Age [mean (SD)] 36.4 (10.2) 36.1 (10.3) 36.5 (9.9) 36.6 (10.3)
Born in the Netherlands (%) 90 94 86 90
Educational level (% max vocational training) 74 76 76 69
With a paying job (%) 66 62 68 70
Somatic disorders
With a disorder (%) 67 69 66 66
Using somatic medication (%) 26 30 23 26
Personality traits (mean scores)
Neuroticism 7.8 7.8 7.8 7.8
Extraversion 3.3 3.2 3.3 3.3
Openness to experience 5.1 5.0 5.4* 5.0
Conscientiousness 3.1 3.3 3.0 3.0
Agreeableness 4.3 4.4 4.2 4.2
Patients using antidepressants (%) 36 39 35 32
DSMIV diagnoses (% of patients)
Any mood disorder 88 88 90 88
Depression, single episode, mild 11 12 12 10
Depression, single episode, moderate 15 16 14 13
Depression, single episode, severe 24 23 28 20
Depression, recurrent, mild 16 14 14 20
Depression, recurrent, moderate 10 10 10 10
Depression, recurrent, severe 11 11 8 12
Dysthymic disorder 27 24 28 28
Any anxiety disorder 53 52 54 53
Panic disorder without agoraphobia 13 13 12 15
Panic disorder with agoraphobia 22 23 21 23
Social phobia 27 26 29 26
Generalized anxiety disorder 4 3 6 3
Mental health functioning (SF36)
Mean score (SD) 27 (9) 27 (9) 26 (8) 28 (9)
Within range of normal population (%) 10 10 7 13
Psychological symptoms (SCL90)
Mean score (SD) 223 (59) 223 (57) 227 (59) 217 (62)
Within range of normal population (%) 11 11 11 13
CAU, care as usual; CBT, cognitive behavioural therapy; BT, brief therapy.
*Statistical significance in comparison with CAU: P < 0.05.
Statistical significance in comparison with BT: P < 0.05.
Patients may have more than one diagnosis.
van Straten et al.
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from (a) mood disorder(s) and 12% only from (an)
anxiety disorder(s). Approximately 90% of all
patients had SCL90 and SF36 scores outside the
range of the normal population and another 5%
scored outside the range on either one of these
measures. Overall, there were few differences
between the three treatment groups at baseline
(Table 1).
Treatment characteristics
Of all 702 patients, 11% (n ¼ 78) did not show up
for treatment (Table 2). Another 16% (n ¼ 111)
did not start with the assigned treatment, because
of administrative errors (e.g. randomization result
got lost) or to deliberate decisions of patients or
therapists who thought that randomization had led
to inappropriate treatment allocation. Patients
randomized to BT more often started with another
type of treatment (21%) than did patients in the
CAU condition (13%; P ¼ 0.02). Overall, there
were no statistically significant baseline differences
between the patients who did not show up, who did
not start with the assigned treatment, and who
started with the assigned treatment.
The differences between the three treatments
were as expected. Brief therapy patients started
soonest after randomization (mean 50 days), had
the fewest sessions (mean 8) and the shortest
treatment duration (mean 178 days; Table 2).
Compared with CAU, these results were all statis-
tically significant, with P < 0.01. Patients in the
CBT condition also finished therapy within a
shorter period of time (mean 223 days) and
with fewer sessions (mean 10) than CAU patients
(P ¼ 0.10 and P ¼ 0.04 respectively).
Only 10% of the CAU patients were referred to
another treatment (after termination of the
first) compared with 18% of the CBT patients
(P ¼ 0.03) and 24% of the BT patients (P < 0.01).
This was expected, since both CBT and BT are the
first step in a stepped care approach. This also
explains why the mean number of sessions for both
CBT and BT exceeded the maximum number of
sessions as described in the treatment protocols (15
sessions for CBT and seven for BT).
Health outcomes and the association with the treatment
conditions
Overall, patients health improved significantly
over time. The SF36 mental health composite
score improved from 27 (SD 9) at baseline to 40
(SD 13) after 12 months, and 43 (SD 13) after
18 months. The SCL90 score improved from 223
(SD 59) at baseline to 171 (SD 66) after 12 months
and 156 (SD 56) after 18 months. After 1 year,
51% of the patients had achieved full recovery
from the DSM-IV mood and anxiety disorders. Of
those recovered patients 52% had SF36 and
SCL90 scores within the range of the normal
population, which is defined as a score of maxi-
mally one SD above the population mean (16, 17).
At the end of the study, two-thirds (66%) of the
patients were recovered from their DSM-IV disor-
der and 60% of those (40% of all patients) had
SF36 and SCL90 scores within the normal range.
This means that 1 year after baseline 27% of all
patients were fully recovered on all three reported
outcomes, a figure that increased to 40% at the end
of the study.
Figure 2 shows that both CBT and BT patients
more often achieved recovery of the DSM-IV
mood and anxiety disorders, at 1 year and at the
end of the study, than did CAU patients. More-
over, the SCL90 and SF36 scores of the CBT and
BT patients improved more over time than the
mental health of the CAU patients. However, all
results were statistically non-significant (Table 3).
All analyses were repeated after imputation of
missing values both with last observation carried
forward en with imputation by regression. The
effect sizes remained roughly the same (results
available at request).







Start treatment (% of patients)
Randomized treatment 75 72 71
Other treatment 13 15 21*
No show 12 13 8
Days after randomization before
start treatment
Unknown (%) 8 7 4
Mean number of days (SD) 89 (69) 83 (58) 50 (43)*
Number of sessions
Unknown (%) 2 3 2
Mean number (SD) 12 (14) 10 (7) 8 (11)*
Treatment duration
Unknown (%) 8 7 4
Mean number of days (SD) 265 (232) 223 (180)* 178 (176)*
Termination of treatment
(% of patients)
Unknown 12 2* 3*
Treatment not yet finished at
end of study
7 2* 2*
Mutual agreement 50 55 54
Mutual agreement with referral 10 18* 24*
Dropped out 20 23 17
CAU, care as usual; CBT, cognitive behavioural therapy; BT, brief therapy.
*Statistical significance in comparison with CAU: P < 0.05.
Statistical significance in comparison with CBT: P < 0.05.
Patients treated with CBT or BT by therapists who were trained in the study
protocol.
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Discussion
This trial performed in daily practice of out-patient
MHCs showed that a stepped-care approach,
where either BT or CBT is offered as a first step,
is at least as effective as a matched-care approach
for patients with mild to severe mood and/or
anxiety disorders, with and without psychiatric and
somatic co-morbidity. The stepped-care approach
with BT as a first step was more efficient as
significantly fewer sessions were needed to obtain
similar treatment results as in the other two
approaches. At the end of the study, two-thirds
of the patients were recovered from their DSM-IV
disorder and 40% of all patients also had SF36 and
SCL90 scores within the normal range.
Although there were patients who refused to
enter the study, as well as patients who dropped
out of the study or the treatment, we could not find
indications of selection bias. Firstly, the patients in
our trial reported more (severe) psychological
symptoms at baseline (mean SCL90 score 223)
than a reference population of arbitrarily chosen
Dutch out-patient psychiatric patients (mean
SCL90 score 204), implying that our study was
not skewed towards the healthier patients. Sec-
ondly, apart from a difference on the personality
trait agreeableness, we could not demonstrate
significant differences with regard to the mental
health status between patients who did and did not
complete the study. Thirdly, the results on the
completer’s analyses (patients who started and
completed the assigned treatment) were not differ-
ent from the intention to treat analyses. Lastly, the
treatment drop out in our study is comparable with
that of other out-patient treatment studies (22, 23),
and, even more importantly, to the general Dutch
MHC population of patients with a mood or
anxiety disorder (5).
The relatively high percentage of patients who
were randomized to BT, but received another type
of treatment (21%) probably reflects the reluctance
of therapists to work with a stepped care model
and to offer a minimal intervention to patients.
Normally, about 20% of all Dutch MHC patients
receive BT. These are preferably patients with mild
depressive disorders with a recent onset, and with
problems related to personal relations or work (11,
24). It has been shown before that therapists are
reluctant to apply BT in the case of personality
disorders and symptoms of anxiety (25). Our study
shows that it is difficult to fully implement a
stepped-care model in routine practice at this
moment. Nevertheless, our findings also indicate
that the majority of patients (in our study 71%,
instead of the usual 20%) with mood or anxiety
disorders (including both mild and severe cases,











DSM-IV diagnoses absent DSM-IV diagnoses present
Fig. 2. Recovery in terms of absence of a DSM-IV diagnosis of
mood or anxiety disorders, both 12 month after baseline and at
the end of the study (18–24 months after baseline).
Table 3. The association between the three types of psychological treatment and the outcomes
Months
CIDI – no anxiety/mood disorder SF36 – good mental health SCL90 – many psychological complaints
T0-12 T0 –12/18/24§ T0 to 18 T0 to 18
ITT
CAU 1.0 (reference) 1.0 (reference) 0.0 (reference) 0.0 (reference)
CBT 1.36 (0.87–2.12) 1.26 (0.81–1.98) 0.73 ()0.69/2.14) )2.18 ()4.93/0.57)
BT 1.48 (0.94–2.32)* 1.41 (0.89/)2.25) 0.56 ()0.87/1.99) 0.12 ()2.96/3.19)
Treatment completers
CAU 1.0 (reference) 1.0 (reference) 0.0 reference 0.0 reference
CBT 1.51 (0.86–2.63) 1.21 (0.69–2.14) 1.27 ()0.54/3.08) )2.27 ()5.79/1.25)
BT 1.65 (0.94–2.89)** 1.79 (0.96–3.34)*** 1.41 ()0.34/3.15) )2.27 ()6.26/1.71)
CAU, care as usual; CBT, cognitive behavioural therapy; BT, brief therapy.
*P ¼ 0.09; **P ¼ 0.08; ***P ¼ 0.07.
Values are expressed as OR (95% CI).
Values are expressed as b(95% CI); the beta coefficient represents the mean difference over time in the SF36 (score ranges from 0 to 100), and the SCL90 (score ranges from
90 to 450).
§Analyses were corrected for time of assessment.
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co-morbidity) may be offered BT because on
average there are no negative consequences for
the mental health of the patients.
In a review of efficacy and effectiveness of
psychotherapy Lambert and Ogles (22) described
that in clinical trials, 40–70% of the patients show
substantial benefit. The results of our trial fit within
this range although our figures are more inclined
towards the lower limit: 12 months after baseline
about half of all patients had recovered from the
mood and anxiety disorders while half of those
patients also had psychological health and quality of
life scores within the range of the general popula-
tion. At the end of the study about two-thirds had
achieved recovery and almost two-thirds of them
had normal psychological health and quality of life
scores. The lower limits effects may be caused by our
specific choice to perform this trial in daily practice
with average qualified therapists and normalMHC
patients (many with psychiatric and/or somatic
co-morbidity). Most RCT’s are performed under
more ideal conditions, within university settings and
more homogeneous patient groups, and may hence
demonstrate larger effects. The finding that about
one-third to half of all patients who recovered from
theDSM-IVdisorder still hadSCL90or SF36 scores
below population level is in concordance with other
clinical and population studies in which residual
effects on functioning after DSM-IV recovery have
been demonstrated (26).
We could not demonstrate any statistically
significant differences in effectiveness between the
treatments because recovery might predominantly
be determined by common therapy factors (e.g.
talking in a structured way about psychological
complaints), characteristics of the therapists (e.g.
the ability to establish a high quality working
relation with the patient), natural recovery and/or
use of antidepressant medication (27–30). This
implies that the window for improvement attrib-
uted to (differences in) psychological treatments is
small. The power of our study was based on a 15%
difference in outcomes between Matched Care and
either one of the stepped-care approaches. We did
not include enough patients to be able to detect the
actual 8% difference in recovery rates with statis-
tical significance. Yet, although not statistically
significant, all results were in favour of the stepped-
care approach. Therefore, we conclude that
patients do not necessarily benefit more from
matched care with more intensive treatments than
from stepped care with a low intensity treatment as
a first step. From an efficiency point of view we
recommend a stepped care approach with BT as a
first step. This is confirmed by our cost-effective-
ness analyses (31).
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